Welcome to LookChem.com Sign In|Join Free

CAS

  • or
5-Amino-8-hydroxyquinoline is a chemical compound belonging to the group of organic compounds known as aminoquinolines and quinolones, characterized by a quinoline structure with an amino group. It is known for its multi-functional applications and has a yellowish appearance. However, it should be handled with caution due to its potential to cause skin irritation, eye damage, and respiratory irritation.

13207-66-4 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 13207-66-4 Structure
  • Basic information

    1. Product Name: 5-Amino-8-hydroxyquinoline
    2. Synonyms: 5-AMINO-8-HYDROXYQUINOLINE;5-Amino-8-hydroxyqui;5-Amino-8-hydroxyquinoline HClsalt
    3. CAS NO:13207-66-4
    4. Molecular Formula: C9H8N2O
    5. Molecular Weight: 160.17
    6. EINECS: 1533716-785-6
    7. Product Categories: N/A
    8. Mol File: 13207-66-4.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 408.3 °C at 760 mmHg
    3. Flash Point: 200.7 °C
    4. Appearance: /
    5. Density: 1.363g/cm3
    6. Vapor Pressure: 3E-07mmHg at 25°C
    7. Refractive Index: 1.759
    8. Storage Temp.: 2-8°C(protect from light)
    9. Solubility: N/A
    10. CAS DataBase Reference: 5-Amino-8-hydroxyquinoline(CAS DataBase Reference)
    11. NIST Chemistry Reference: 5-Amino-8-hydroxyquinoline(13207-66-4)
    12. EPA Substance Registry System: 5-Amino-8-hydroxyquinoline(13207-66-4)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 13207-66-4(Hazardous Substances Data)

13207-66-4 Usage

Uses

Used in Coordination Chemistry:
5-Amino-8-hydroxyquinoline is used as a ligand in coordination chemistry for forming complexes with transition metals, such as copper. These complexes have shown anticancer properties, making them a promising avenue for cancer research and treatment.
Used in Antibacterial Applications:
5-Amino-8-hydroxyquinoline is used as a potential antibiotic agent for inhibiting the growth of certain bacteria. Studies have indicated its effectiveness in this area, suggesting that it could be a valuable addition to the arsenal of antibiotics available for combating bacterial infections.

Check Digit Verification of cas no

The CAS Registry Mumber 13207-66-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,3,2,0 and 7 respectively; the second part has 2 digits, 6 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 13207-66:
(7*1)+(6*3)+(5*2)+(4*0)+(3*7)+(2*6)+(1*6)=74
74 % 10 = 4
So 13207-66-4 is a valid CAS Registry Number.
InChI:InChI=1/C9H8N2O/c10-7-3-4-8(12)9-6(7)2-1-5-11-9/h1-5,12H,10H2

13207-66-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-aminoquinolin-8-ol

1.2 Other means of identification

Product number -
Other names 8-Quinolinol, 5-amino-

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:13207-66-4 SDS

13207-66-4Synthetic route

nitroxoline
4008-48-4

nitroxoline

5-amino-8-hydroxyquinoline
13207-66-4

5-amino-8-hydroxyquinoline

Conditions
ConditionsYield
With palladium 10% on activated carbon; hydrogen In methanol for 3.5h; Schlenk technique; Inert atmosphere;98%
With sodium dithionite In tetrahydrofuran; water at 55℃; for 0.25h; Inert atmosphere;63%
With 5%-palladium/activated carbon; hydrazine hydrate In water; isopropyl alcohol for 7h; Reflux;50.8%
5-Nitroso-8-hydroxyquinoline hydrochloride
63450-86-2

5-Nitroso-8-hydroxyquinoline hydrochloride

5-amino-8-hydroxyquinoline
13207-66-4

5-amino-8-hydroxyquinoline

Conditions
ConditionsYield
With sodium hydroxide; sodium dithionite In water at 40 - 45℃;83%
With sodium dithionite; sulfuric acid; sodium hydroxide Inert atmosphere;
5-nitroso-8-hydroxyquinoline
3565-26-2

5-nitroso-8-hydroxyquinoline

5-amino-8-hydroxyquinoline
13207-66-4

5-amino-8-hydroxyquinoline

Conditions
ConditionsYield
With hydrogenchloride; tin In water for 6h; Reflux;79.87%
With nickel; acetone Hydrogenation;
With ethanol; nickel Hydrogenation;
5,8-quinolinoquinone 5-oxime
109701-95-3

5,8-quinolinoquinone 5-oxime

phenylhydrazine
100-63-0

phenylhydrazine

5-amino-8-hydroxyquinoline
13207-66-4

5-amino-8-hydroxyquinoline

Conditions
ConditionsYield
at 100℃;
5-nitroquinoline
607-34-1

5-nitroquinoline

5-amino-8-hydroxyquinoline
13207-66-4

5-amino-8-hydroxyquinoline

Conditions
ConditionsYield
With sulfate solution elektrolytische Reduktion;
p-<(8-hydroxy-5-quinolyl)azo>benzenesulphonamide
16588-39-9

p-<(8-hydroxy-5-quinolyl)azo>benzenesulphonamide

A

5-amino-8-hydroxyquinoline
13207-66-4

5-amino-8-hydroxyquinoline

B

sulfanilamide
63-74-1

sulfanilamide

Conditions
ConditionsYield
In water; N,N-dimethyl-formamide for 1.5h; electrolysis at dropping mercury electrode;
5-nitroquinoline
607-34-1

5-nitroquinoline

sulfuric acid
7664-93-9

sulfuric acid

5-amino-8-hydroxyquinoline
13207-66-4

5-amino-8-hydroxyquinoline

Conditions
ConditionsYield
Electrolysis;
5-nitroso-8-oxy-quinoline

5-nitroso-8-oxy-quinoline

5-amino-8-hydroxyquinoline
13207-66-4

5-amino-8-hydroxyquinoline

Conditions
ConditionsYield
With phenylhydrazine
With hydrogen sulfide; ammonia
5-nitroso-quinolin-8-ol hydrochloride

5-nitroso-quinolin-8-ol hydrochloride

5-amino-8-hydroxyquinoline
13207-66-4

5-amino-8-hydroxyquinoline

Conditions
ConditionsYield
With hydrogenchloride; tin(ll) chloride
5-nitroso-quinolin-8-ol sulfate

5-nitroso-quinolin-8-ol sulfate

5-amino-8-hydroxyquinoline
13207-66-4

5-amino-8-hydroxyquinoline

Conditions
ConditionsYield
With ammonium hydroxide; sodium hydrogensulfite
-<4 azo 5>-<8-oxy-quinoline>

-<4 azo 5>-<8-oxy-quinoline>

5-amino-8-hydroxyquinoline
13207-66-4

5-amino-8-hydroxyquinoline

Conditions
ConditionsYield
With hydrogenchloride; tin(ll) chloride
hydrochloride of 5-nitroso-8-oxy-quinoline

hydrochloride of 5-nitroso-8-oxy-quinoline

5-amino-8-hydroxyquinoline
13207-66-4

5-amino-8-hydroxyquinoline

Conditions
ConditionsYield
With hydrogenchloride; tin(ll) chloride
8-hydroxy-5-hydroxyamino-quinoline-6-sulfonic acid

8-hydroxy-5-hydroxyamino-quinoline-6-sulfonic acid

ammonia
7664-41-7

ammonia

Na2S2O4

Na2S2O4

5-amino-8-hydroxyquinoline
13207-66-4

5-amino-8-hydroxyquinoline

phenetol-<4 azo 5>-<8-oxy-quinoline>

phenetol-<4 azo 5>-<8-oxy-quinoline>

5-amino-8-hydroxyquinoline
13207-66-4

5-amino-8-hydroxyquinoline

Conditions
ConditionsYield
With hydrogenchloride; tin
hydrogenchloride
7647-01-0

hydrogenchloride

5,8-quinolinoquinone 5-oxime
109701-95-3

5,8-quinolinoquinone 5-oxime

tin dichloride

tin dichloride

5-amino-8-hydroxyquinoline
13207-66-4

5-amino-8-hydroxyquinoline

Conditions
ConditionsYield
Reaktion des Hydrochlorids;
hydrogenchloride
7647-01-0

hydrogenchloride

5-[(E)-2-(4'-ethoxyphenyl)-1-(diazenyl)]quinolin-8-ol
75907-28-7

5-[(E)-2-(4'-ethoxyphenyl)-1-(diazenyl)]quinolin-8-ol

tin

tin

5-amino-8-hydroxyquinoline
13207-66-4

5-amino-8-hydroxyquinoline

(E)-4-((8-hydroxyquinolin-5-yl)diazenyl)benzenesulfonic acid
574-70-9

(E)-4-((8-hydroxyquinolin-5-yl)diazenyl)benzenesulfonic acid

HCl-salt tin dichloride solution

HCl-salt tin dichloride solution

A

5-amino-8-hydroxyquinoline
13207-66-4

5-amino-8-hydroxyquinoline

B

4-aminobenzene sulfonic acid
121-57-3

4-aminobenzene sulfonic acid

5-amino-8-hydroxyquinoline dihydrochloride
21302-43-2

5-amino-8-hydroxyquinoline dihydrochloride

5-amino-8-hydroxyquinoline
13207-66-4

5-amino-8-hydroxyquinoline

Conditions
ConditionsYield
With sodium hydrogencarbonate In water pH=7.5;740 mg
nitroxoline
4008-48-4

nitroxoline

A

5-amino-8-hydroxyquinoline
13207-66-4

5-amino-8-hydroxyquinoline

B

5-(hydroxyamino)quinolin-8-ol

5-(hydroxyamino)quinolin-8-ol

Conditions
ConditionsYield
With hydrazine hydrate In chloroform for 2h; chemoselective reaction;
8-quinolinol
148-24-3

8-quinolinol

5-amino-8-hydroxyquinoline
13207-66-4

5-amino-8-hydroxyquinoline

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: hydrogenchloride; sodium nitrite / water / 1 h / 0 - 4 °C
2: sodium dithionite; sulfuric acid; sodium hydroxide / Inert atmosphere
View Scheme
Multi-step reaction with 3 steps
1: sulfuric acid; sodium nitrite
2: sulfuric acid; nitric acid
3: hydrogenchloride; tin(ll) chloride / water / 80 °C
View Scheme
5-amino-8-hydroxyquinoline
13207-66-4

5-amino-8-hydroxyquinoline

5-acetyl-2-ethyl-4-nitro-6-phenylpyridazin-3(2H)-one
189306-94-3

5-acetyl-2-ethyl-4-nitro-6-phenylpyridazin-3(2H)-one

5-acetyl-2-ethyl-4-((8-hydroxyquinolin-5-yl)amino)-6-phenylpyridazin-3(2H)-one
720717-72-6

5-acetyl-2-ethyl-4-((8-hydroxyquinolin-5-yl)amino)-6-phenylpyridazin-3(2H)-one

Conditions
ConditionsYield
In ethanol at 20℃; for 40h;90%
5-amino-8-hydroxyquinoline
13207-66-4

5-amino-8-hydroxyquinoline

6,7-dimethoxy-4-chloroquinazoline
13790-39-1

6,7-dimethoxy-4-chloroquinazoline

4-[(3'-hydroxyquiline)-5]-amino-6,7-dimethoxyquinazoline

4-[(3'-hydroxyquiline)-5]-amino-6,7-dimethoxyquinazoline

Conditions
ConditionsYield
In ethanol for 4h; Reflux;85%
5-amino-8-hydroxyquinoline
13207-66-4

5-amino-8-hydroxyquinoline

4-ethylbenzylaldehyde
4748-78-1

4-ethylbenzylaldehyde

C18H16N2O

C18H16N2O

Conditions
ConditionsYield
In ethanol for 4h; Reflux;83%
5-amino-8-hydroxyquinoline
13207-66-4

5-amino-8-hydroxyquinoline

benzaldehyde
100-52-7

benzaldehyde

5-(benzylidene)amino-8-hydroxyquinoline
1236049-61-8

5-(benzylidene)amino-8-hydroxyquinoline

Conditions
ConditionsYield
With formic acid In ethanol at 85℃; for 5h;80.6%
With formic acid In ethanol at 83℃; for 4h;78.2%
With sulfuric acid In ethanol Reflux;
pyridine-4-carbaldehyde
872-85-5

pyridine-4-carbaldehyde

5-amino-8-hydroxyquinoline
13207-66-4

5-amino-8-hydroxyquinoline

5-((pyridin-4-ylmethylene)amino)quinolin-8-ol

5-((pyridin-4-ylmethylene)amino)quinolin-8-ol

Conditions
ConditionsYield
With formic acid In ethanol at 85℃; for 5h;80.2%
5-amino-8-hydroxyquinoline
13207-66-4

5-amino-8-hydroxyquinoline

9-anthracene aldehyde
642-31-9

9-anthracene aldehyde

5-(9-anthranylene)-8-hydroxyquinoline

5-(9-anthranylene)-8-hydroxyquinoline

Conditions
ConditionsYield
In methanol for 6h; Reflux;71%
5-amino-8-hydroxyquinoline
13207-66-4

5-amino-8-hydroxyquinoline

salicylaldehyde
90-02-8

salicylaldehyde

C17H13NO2

C17H13NO2

Conditions
ConditionsYield
With formic acid In ethanol at 70 - 80℃; for 3h;69%
5-amino-8-hydroxyquinoline
13207-66-4

5-amino-8-hydroxyquinoline

5,8-quinolinedione
10470-83-4

5,8-quinolinedione

Conditions
ConditionsYield
With sodium dichromate; sulfuric acid In dichloromethane; water at 0℃; for 1h;61%
50%
With potassium dichromate; sulfuric acid
With sulfuric acid In water at 0℃; for 0.5h;
5-amino-8-hydroxyquinoline
13207-66-4

5-amino-8-hydroxyquinoline

acryloyl chloride
814-68-6

acryloyl chloride

N-(8-hydroxy-quinolin-5-yl)-acrylamide
65930-22-5

N-(8-hydroxy-quinolin-5-yl)-acrylamide

Conditions
ConditionsYield
With triethylamine In dichloromethane50%
5-amino-8-hydroxyquinoline
13207-66-4

5-amino-8-hydroxyquinoline

tert-butyldimethylsilyl chloride
18162-48-6

tert-butyldimethylsilyl chloride

(8-((tert-butyldimethylsilyl)oxy)quinolin-5-amine)

(8-((tert-butyldimethylsilyl)oxy)quinolin-5-amine)

Conditions
ConditionsYield
With 1H-imidazole In dichloromethane at 20℃; for 4h;40%
With 1H-imidazole In dichloromethane
pyridine-2-carbaldehyde
1121-60-4

pyridine-2-carbaldehyde

5-amino-8-hydroxyquinoline
13207-66-4

5-amino-8-hydroxyquinoline

5-[(pyridin-2-ylmethylene)-amino]quinolin-8-ol

5-[(pyridin-2-ylmethylene)-amino]quinolin-8-ol

Conditions
ConditionsYield
With acetic acid In ethanol for 3h; Reflux;7%
5-amino-8-hydroxyquinoline
13207-66-4

5-amino-8-hydroxyquinoline

acetic anhydride
108-24-7

acetic anhydride

N-(8-hydroxyquinolin-5-yl)acetamide
65618-64-6

N-(8-hydroxyquinolin-5-yl)acetamide

Conditions
ConditionsYield
With diethyl ether; sodium acetate
5-amino-8-hydroxyquinoline
13207-66-4

5-amino-8-hydroxyquinoline

benzaldehyde
100-52-7

benzaldehyde

2-oxo-propionic acid
127-17-3

2-oxo-propionic acid

6-hydroxy-2-phenyl-[1,7]phenanthroline-4-carboxylic acid

6-hydroxy-2-phenyl-[1,7]phenanthroline-4-carboxylic acid

Conditions
ConditionsYield
With ethanol
5-amino-8-hydroxyquinoline
13207-66-4

5-amino-8-hydroxyquinoline

benzoyl chloride
98-88-4

benzoyl chloride

N-(8-hydroxyquinolin-5-yl)benzamide
92868-24-1

N-(8-hydroxyquinolin-5-yl)benzamide

Conditions
ConditionsYield
With pyridine
5-amino-8-hydroxyquinoline
13207-66-4

5-amino-8-hydroxyquinoline

benzoyl chloride
98-88-4

benzoyl chloride

5-benzoylamino-8-benzoyloxy-quinoline
65618-63-5

5-benzoylamino-8-benzoyloxy-quinoline

Conditions
ConditionsYield
With alkaline solution
5-amino-8-hydroxyquinoline
13207-66-4

5-amino-8-hydroxyquinoline

propionic acid anhydride
123-62-6

propionic acid anhydride

N-(8-hydroxy-[5]quinolyl)-propionamide
75653-04-2

N-(8-hydroxy-[5]quinolyl)-propionamide

5-amino-8-hydroxyquinoline
13207-66-4

5-amino-8-hydroxyquinoline

2-(diethylamino)ethyl chloride
100-35-6

2-(diethylamino)ethyl chloride

5-(2-diethylamino-ethylamino)-quinolin-8-ol; dihydrochloride

5-(2-diethylamino-ethylamino)-quinolin-8-ol; dihydrochloride

Conditions
ConditionsYield
With benzene
5-amino-8-hydroxyquinoline
13207-66-4

5-amino-8-hydroxyquinoline

5-bromo-8-hydroxyquinoline
1198-14-7

5-bromo-8-hydroxyquinoline

Conditions
ConditionsYield
Diazotization;
With water; hydrogen bromide Diazotization.Beim Erhitzen einer Diazoniumsalz-Loesung mit Kupfer(I)-bromid;

13207-66-4Relevant articles and documents

Four tetra-nuclear lanthanide complexes based on 8-hydroxyquinolin derivatives: magnetic refrigeration and single-molecule magnet behaviour

Fang, Ming,Shao, Li-Jun,Shi, Tian-Xing,Chen, Ying-Ying,Yu, Hong,Li, Peng-Fei,Wang, Wen-Min,Zhao, Bin

, p. 11847 - 11853 (2018)

Four tetra-nuclear lanthanide complexes: {[Ln4(L)6(tmhd)4(μ3-OH)2]·mH2O} (Ln = Gd (1, m = 0), Tb (2, m = 3), Dy (3, m = 0), Ho (4, m = 0); L = 5-((pyridin-4-ylmethylene)amino)quinolin-8-ol, tmhd = 2,2,6,6-tetramethylheptane-3,5-dione) were fabricated and structurally characterized. Compounds 1-4 are isostructural and belong to the monoclinic system with space group P21/n. The cores of the complexes contain a tetranuclear arrangement of LnIII ions, which is bridged by the two pyramidal μ3-OH- ions, and the four LnIII ions are precisely coplanar. The magnetic study reveals that 1 exhibits cryogenic magnetic refrigeration property (-ΔSm = 20.85 J K-1 kg-1), whereas compound 3 exhibits slow relaxation of the magnetization.

The Synthesis of Quinoline-based Tin Complexes with Pendant Schiff Bases

Butler, Patrick W. V.,Ward, Jas S.

, p. 694 - 699 (2019)

Whilst pursuing the synthetic utility of quinoline-based tin complexes, Me2Sn(Quin-NO2)2 (1) and Ph2Sn(Quin-NO2)2 (2) (Quin-NO2 = 5-nitroquinolino-8-oate) were synthesized bearing coordinatively inert nitro groups. Conventional reduction methodologies successfully converted 1 to Me2Sn(Quin-NH2)2 (3) and 2 to Ph2Sn(Quin-NH2)2 (4) (Quin-NH2 = 5-aminoquinolino-8-oate). The synthetically useful amine groups proved difficult to exploit in the presence of the central tin atom, however, a complete Schiff base functionalized Sn complex of the dimethyltin pro-ligand Me2Sn(Quin-py)2 (6) was successfully synthesized from 5-[(pyridin-2-ylmethylene)amino]quinolin-8-ol (HQuin-py; 5) in good yield via an alternative strategy exploiting the oxophilic tendencies of tin. All species were fully characterized by NMR (including 119Sn NMR spectroscopy), HR-ESI MS and single-crystal X-ray diffraction, and preliminary studies of their supramolecular potential are also discussed.

Structures, magnetic refrigeration and single molecule-magnet behavior of five rhombus-shaped tetranuclear Ln(iii)-based clusters

Cui, Jian-Zhong,Fang, Ming,Gao, Hong-Ling,Huai, Lei,Jiang, Kai-Jun,Shen, Hai-Yun,Wang, Wen-Min,Wang, Xi-Wen

, p. 10266 - 10274 (2020)

A series of coplanar tetranuclear Ln(iii)-based clusters, namely [Ln4(acac)4(L)6(μ3-OH)2]·[solvent] (Ln = Eu (1), Gd (2), Tb (3), Dy (4) and Er (5)), have been synthesized by using an 8-hydroxyquinoline Schiff base ligand (HL = 5-(2-thenylidene)-8-hydroxylquinoline) and acetylacetone. Their structures and magnetic properties have been completely characterized. The structure determination shows that clusters 1-5 are isostructural with a rhombus-shaped Ln4 core. The magnetic studies reveal that the Gd4 cluster (2) displays cryogenic magnetocaloric effects with a maximum-ΔSm value of 22.09 J kg-1 K-1 at 2.5 K and ΔH = 7.0 T; while ac susceptibility measurements show that single molecule-magnet behavior is exhibited by the Dy4 cluster (4) with the anisotropic barrier (ΔE/kB) of 75.01 K. Interestingly, more than one maximal out-of-phase ac signals (χ′′) were observed in 4, suggesting the operation of multiple magnetic relaxation processes in 4. In addition, the solid state luminescence properties reveal that clusters 1, 3, and 4 display the characteristic lanthanum luminescence at room temperature. This journal is

Tetranuclear lanthanide complexes showing magnetic refrigeration and single molecule magnet behavior

Yu, Hong,Yang, Jia-Xing,Han, Ju-Qing,Li, Peng-Fei,Hou, Yin-Ling,Wang, Wen-Min,Fang, Ming

, p. 8067 - 8074 (2019/06/08)

Three tetranuclear lanthanide complexes: {[Ln4(L)6(pbd)4(μ3-OH)2]·2CH3CN} (Ln = Gd (1), Tb (2), Dy (3); HL = 5-(benzylideneamino)quinolin-8-ol, pbd = 1-phenylbutane-1,3-dione) were fabricated and structurally characterized. Compounds 1-3 are isostructural belonging to the triclinic system with space group P1. The core of the complexes contains a tetranuclear arrangement of LnIII ions which is held together by two pyramidal μ3-OH- ions and six μ2 phenol hydroxyl oxygen atoms derived from six L- ligands. Magnetic studies indicated that 1 exhibits cryogenic magnetic refrigeration properties (maximum -ΔSm = 21.41 J K-1 kg-1, ΔH = 7 T at 2.0 K), whereas compound 3 exhibits slow relaxation of the magnetization with an energy barrier (ΔE/kB) of 81.48 K and τ0 = 6.48 × 10-8 s.

G-quadruplex and duplex DNA binding studies of novel Ruthenium(II) complexes containing ascididemin ligands

Wumaier, Maierhaba,Shi, Jing-Jing,Yao, Tian-Ming,Hu, Xiao-Chun,Gao, Ru-Ru,Shi, Shuo

, (2019/04/17)

In this paper, three new Ruthenium(II) polypyridyl complexes containing ascididemin (ASC) as main ligand have been synthesized and characterized. Their interactions with different G-quadruplex (Htelo, c-myc and c-kit) (Htelo: human telomeric DNA, c-myc: cellular-myelocytomatosis viral oncogene, c-kit: oncogene c-kit promoter sequences) and duplex (ds26) DNA sequences were comparatively studied with the free ligand ASC by a series of spectroscopic techniques including UV–vis (ultraviolet-visible) spectroscopy, FID (fluorescent intercalator displacement) assay, and FRET (fluorescence resonance energy transfer) melting assay. Molecular docking studies were also performed to support the binding mode of the compounds with G-quadruplex DNA. Results indicated that [Ru(bpy)2ASC]·(PF6)2 (1), [Ru(phen)2ASC]·(PF6)2 (2), [Ru(tatp)2ASC]·(PF6)2 (3) (bpy = 2,2′?bipyridine, phen = 1,10?phenanthroline, tatp = 1,4,8,9?tetra?aza?triphenylene) and ASC can effectively bind G-quadruplex and duplex DNA and stabilization ability lies in the order 3 > 2 > 1 > ASC. Complex 3 was determined to be the most promising candidate for further in vitro studies and potential anticancer drug.

Study on Relationship Between Fluorescence Properties and Structure of Substituted 8-Hydroxyquinoline Zinc Complexes

Jianbo, He,Tingting, Zhou,Yongjing, Cao,Yuanyuan, Zhang,Weiqing, Yang,Menglin, Ma

, p. 1121 - 1126 (2018/08/17)

Organic light-emitting diodes (OLEDs) produced from 8-hydroxyquinoline metal complexes play a vital role in modern electroluminescent devices. In this manuscript, a series of 8-hydroxyquinoline derivatives were synthesized by different methods and their corresponding zinc metal complexes were prepared. The UV and fluorescence properties of the complexes were measured aiming to understand the effect of substituents at the quinoline ring on the fluorescence properties of the complexes. When the C-5 of 8-hydroxyquinoline was replaced by halogen group, the fluorescence emission wavelengths had been red-shifted, at the same time, blue-shifted of fluorescence emission wavelength was observed when the C-5 position of 8-hydroxyquinoline was substituted by electron-withdrawing group. When the C-4 position of 8-hydroxyquinolie was substituted by methyl or the C-5 position was substituted by sulfonic acid group, the corresponding zinc complexes had higher fluorescence intensity than 8-hydroxyquinolie zinc.

New Aryl Derivatives of Quinolinedione and Related Heterocyclic Compounds

Egu, Samuel Attah,Okoro, Uchechukwu Chris,Onoabedje, Efeturi Abraham

, p. 1572 - 1577 (2017/03/27)

The synthesis of new derivatives of 6,7-dibromoquinoline-5,8-dione and 6,7-dichloroquinoline-5,8-dione via palladium/Sphos-mediated Suzuki–Miyaura cross-coupling reaction is reported. The 6,7-dibromoquinoline-5,8-dione and 6,7-dichloroquinoline-5,8-dione intermediates were prepared in a three-step reaction from 8-hydroxyquinoline. The palladium-catalyzed reactions of 6,7-dibromoquinoline-5,8-dione and 6,7-dichloroquinoline-5,8-dione with a variety of aryl boronic acids provide coupled compounds in high yields. The arylation of 6,7-dibromoquinoline-5,8-dione and 6,7-dichloroquinoline-5,8-dione with 4-bromophenyl boronic acid supplied 6,6′-(1,4-phenylene)bis(7-bromoquinoline-5,8-dione) and (4-(6-(4-(6-chloro-5,8-dihydroquinolin-7-yl)phenyl)-5,8-dihydroquinolin-7-yl)phenyl)boronic acid respectively, in addition to the expected coupled compounds in moderate yields. Also, Pd(0)/PPh3 allowed the 7-chloro-6-(4-nitrophenyl)quinoline-5,8-dione and 7-chloro-6-phenylquinoline-5,8-dione to be synthesized via Heck reaction. The yields of the synthesized target molecules depend largely on the reaction conditions and the type of ligands employed. Structural assignments of the synthesized compounds were established by spectra and analytical data.

Synthesis of N-aryl and N-heteroaryl hydroxylamines via partial reduction of nitroarenes with soluble nanoparticle catalysts

Tyler, Jefferson H.,Nazari, S. Hadi,Patterson, Robert H.,Udumula, Venkatareddy,Smith, Stacey J.,Michaelis, David J.

supporting information, p. 82 - 86 (2016/12/23)

Polystyrene-supported ruthenium nanoparticles enable the selective hydrazine-mediated reduction of nitroarenes to hydroxylamine products in high yield and selectivity. Key to obtaining the hydroxylamine product in good yield was the use of organic solvents capable of solubilizing the polystyrene-supported nanoparticle catalyst. N-aryl and N-heteroaryl hydroxylamines are generated under exceptionally mild conditions and in the presence of a various easily reduced functional groups.

Design, synthesis and biological evaluation of ezrin inhibitors targeting metastatic osteosarcoma

Paige, Mikell,Kosturko, George,Bulut, Güllay,Miessau, Matthew,Rahim, Said,Toretsky, Jeffrey A.,Brown, Milton L.,üren, Aykut

, p. 478 - 487 (2014/01/17)

Respiratory failure due to pulmonary metastasis is the major cause of death for patients with osteosarcoma. However, the molecular basis for metastasis of osteosarcoma is poorly understood. Recently, ezrin, a member of the ERM family of proteins, has been associated with osteosarcoma metastasis to the lungs. The small molecule NSC 668394 was identified to bind to ezrin, inhibit in vitro and in vivo cell migration, invasion, and metastatic colony survival. Reported herein are the design and synthesis of analogues of NSC 668394, and subsequent functional ezrin inhibition studies. The binding affinity was characterized by surface plasmon resonance technique. Cell migration and invasion activity was determined by electrical cell impedance methodology. Optimization of a series of heterocyclic-dione analogues led to the discovery of compounds 21k and 21m as potential novel antimetastatic agents.

Synthesis, characterization, screening and docking analysis of 4-anilinoquinazoline derivatives as tyrosine kinase inhibitors

Lue, Shuang,Zheng, Wei,Ji, Liyun,Luo, Qun,Hao, Xiang,Li, Xianchan,Wang, Fuyi

, p. 84 - 94 (2013/04/23)

We report here the design and synthesis of a series of 4-anilinoquinazoline derivatives, of which 7 compounds were crystallographically characterized, as epidermal growth factor receptor (EGFR) inhibitors by modifications on the aniline ring or at the 6-alkoxy site of the 6,7-dimethoxy-4-anilinoquinazoline pharmacophore. The relative inhibition efficiency on EGFR of all as-prepared compounds were measured and ordered, and the IC50 values of nine highly active compounds were determined by ELISA. Docking studies indicated that all 4-anilinoquinazoline derivatives could be inserted into the ATP-binding pocket of the EGFR via indirect docking, and that the modifications at the 3′-position of the anilino group and 6-alkoxy site of the quinazoline ring have little interference with the formation of the two essential H-bonds between the N3 of the quinazoline ring and Thr766 through a water molecule, and the N1 of the quinazoline ring and N-H of Met769. The displacing of the phenyl at 4-position with pyridinyl dramatically reduces the activity of the quinazoline pharmacophore, the resulting derivative (10) being the least active compound. The docking results also showed that the formation of new H-bonds between the N-H of the ethylenediamine group linked to the 6-alkoxy site and Asp776/Cys773 in the binding pocket of EGFR makes compounds 19 (IC50 = 12.1 ± 1.6 nM) and 20 (IC50 = 13.6 ± 0.8 nM) the most potent EGFR inhibitors in this class and worthy of further modification to obtain more potent anticancer compounds.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 13207-66-4